(Dublin, New York, March 19th, 2018) HealthBeacon announces that is has been chosen as the winner of the Johnson & Johnson Innovation, JLABS and Janssen Supply Chain Group, LLC (JSC) Patient Adherence QuickFire Challenge. The announcement was made at the New York Genome Center, home to the new JLABS @ NYC opening in June 2018, in New York, NY, USA. This challenge was designed to identify companies that are creating innovative solutions for patients, that are easy to use and may be integrated into a patient’s typical daily healthcare routine. HealthBeacon was voted as the overall winner of the challenge and as such will receive a $75,000 award.
HealthBeacon was identified as the winner for displaying excellence in the following categories.
- High impact on healthcare outcomes and adherence
- Leap frog innovation & market competitiveness: new methodology & technology feasibility
- User friendly & ease of implementation
- Integrated, holistic solution from Pharma manufacturer to patient
- Commercial scalability
HealthBeacon has a strong understanding of how adherence solutions can be used to improve patient outcomes. HealthBeacon was represented at the event by CTO and Co-Founder Kieran Daly, and Design Director, Kyle Bolton.
HealthBeacon is a Digital Therapeutics company that develops smart tools for managing medication. HealthBeacon has developed an injectable medication management system that tightly monitors patients digitally, keeping them adherent to their prescription and leveraging real time data to drive clinical intervention. This system has been clinically reviewed, validated by the pharmaceutical industry and has been integrated into patient care programs throughout North America and Europe, delivering valuable data to both the patient and their clinical team.